291 related articles for article (PubMed ID: 26104008)
1. FAT1 cadherin acts upstream of Hippo signalling through TAZ to regulate neuronal differentiation.
Ahmed AF; de Bock CE; Lincz LF; Pundavela J; Zouikr I; Sontag E; Hondermarck H; Thorne RF
Cell Mol Life Sci; 2015 Dec; 72(23):4653-69. PubMed ID: 26104008
[TBL] [Abstract][Full Text] [Related]
2. FAT1 cadherin controls neuritogenesis during NTera2 cell differentiation.
Ahmed AF; de Bock CE; Sontag E; Hondermarck H; Lincz LF; Thorne RF
Biochem Biophys Res Commun; 2019 Jun; 514(3):625-631. PubMed ID: 31076104
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
[TBL] [Abstract][Full Text] [Related]
4. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
Zhu J; Wu T; Lin Q
Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
[TBL] [Abstract][Full Text] [Related]
5. The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells.
Slaninová V; Heron-Milhavet L; Robin M; Jeanson L; Aissanou A; Kantar D; Tosi D; Bréhélin L; Gongora C; Djiane A
BMC Cancer; 2024 May; 24(1):587. PubMed ID: 38741073
[TBL] [Abstract][Full Text] [Related]
6. The Hippo Signaling Transducer TAZ Regulates Mammary Gland Morphogenesis and Carcinogen-induced Mammary Tumorigenesis.
Denson KE; Mussell AL; Shen H; Truskinovsky A; Yang N; Parashurama N; Chen Y; Frangou C; Yang F; Zhang J
Sci Rep; 2018 Apr; 8(1):6449. PubMed ID: 29691438
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components.
Kim NG; Koh E; Chen X; Gumbiner BM
Proc Natl Acad Sci U S A; 2011 Jul; 108(29):11930-5. PubMed ID: 21730131
[TBL] [Abstract][Full Text] [Related]
8. Activation of the Hippo/TAZ pathway is required for menstrual stem cells to suppress myofibroblast and inhibit transforming growth factor β signaling in human endometrial stromal cells.
Zhu H; Pan Y; Jiang Y; Li J; Zhang Y; Zhang S
Hum Reprod; 2019 Apr; 34(4):635-645. PubMed ID: 30715393
[TBL] [Abstract][Full Text] [Related]
9. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
[TBL] [Abstract][Full Text] [Related]
10. Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells.
Van Sciver N; Ohashi M; Pauly NP; Bristol JA; Nelson SE; Johannsen EC; Kenney SC
PLoS Pathog; 2021 Aug; 17(8):e1009783. PubMed ID: 34339458
[TBL] [Abstract][Full Text] [Related]
11. The Hippo signaling pathway: from multiple signals to the hallmarks of cancers.
Zhu N; Yang R; Wang X; Yuan L; Li X; Wei F; Zhang L
Acta Biochim Biophys Sin (Shanghai); 2023 Mar; 55(6):904-913. PubMed ID: 36942989
[TBL] [Abstract][Full Text] [Related]
12. The Hippo signaling pathway is required for salivary gland development and its dysregulation is associated with Sjogren's syndrome.
Enger TB; Samad-Zadeh A; Bouchie MP; Skarstein K; Galtung HK; Mera T; Walker J; Menko AS; Varelas X; Faustman DL; Jensen JL; Kukuruzinska MA
Lab Invest; 2013 Nov; 93(11):1203-18. PubMed ID: 24080911
[TBL] [Abstract][Full Text] [Related]
13. Hippo-Yap/Taz signaling: Complex network interactions and impact in epithelial cell behavior.
van Soldt BJ; Cardoso WV
Wiley Interdiscip Rev Dev Biol; 2020 May; 9(3):e371. PubMed ID: 31828974
[TBL] [Abstract][Full Text] [Related]
14. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1.
Janse van Rensburg HJ; Azad T; Ling M; Hao Y; Snetsinger B; Khanal P; Minassian LM; Graham CH; Rauh MJ; Yang X
Cancer Res; 2018 Mar; 78(6):1457-1470. PubMed ID: 29339539
[TBL] [Abstract][Full Text] [Related]
15. TAZ activation by Hippo pathway dysregulation induces cytokine gene expression and promotes mesothelial cell transformation.
Matsushita A; Sato T; Mukai S; Fujishita T; Mishiro-Sato E; Okuda M; Aoki M; Hasegawa Y; Sekido Y
Oncogene; 2019 Mar; 38(11):1966-1978. PubMed ID: 30401981
[TBL] [Abstract][Full Text] [Related]
16. Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis.
Patel SH; Camargo FD; Yimlamai D
Gastroenterology; 2017 Feb; 152(3):533-545. PubMed ID: 28003097
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
18. The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer.
Li Z; Wang Y; Zhu Y; Yuan C; Wang D; Zhang W; Qi B; Qiu J; Song X; Ye J; Wu H; Jiang H; Liu L; Zhang Y; Song LN; Yang J; Cheng J
Mol Oncol; 2015 Jun; 9(6):1091-105. PubMed ID: 25704916
[TBL] [Abstract][Full Text] [Related]
19. The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma.
Mohamed A; Sun C; De Mello V; Selfe J; Missiaglia E; Shipley J; Murray GI; Zammit PS; Wackerhage H
J Pathol; 2016 Sep; 240(1):3-14. PubMed ID: 27184927
[TBL] [Abstract][Full Text] [Related]
20. A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer.
Romero-Pérez L; Garcia-Sanz P; Mota A; Leskelä S; Hergueta-Redondo M; Díaz-Martín J; López-García MA; Castilla MA; Martínez-Ramírez A; Soslow RA; Matias-Guiu X; Moreno-Bueno G; Palacios J
Mod Pathol; 2015 Nov; 28(11):1492-503. PubMed ID: 26381823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
